ArticleMedicine2026
Quantitative evaluation of nursing intervention efficacy in high-risk hypertensive disorders of pregnancy: A retrospective quasi-experimental study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertensive disorders of pregnancy (HDP) contribute significantly to maternal and neonatal morbidity. Precision medicine emphasizes individualized risk prediction, while nursing interventions (NIs) address behavioral and psychosocial care. This study evaluated the clinical benefit of a structured NI compared to routine prenatal care in reducing complications among women diagnosed with HDP. This retrospective quasi-experimental study was conducted at Peking University Shenzhen Hospital. Participants were primigravida Chinese women (median age 25 years) with a confirmed diagnosis of HDP. Of 3260 screened women, 265 met the inclusion criteria: gestational hypertension (48%), preeclampsia (31%), or superimposed preeclampsia (21%). Risk was initially assessed via self-reported questionnaires starting at 15 gestational weeks until 7 days postpartum. Participants were allocated to either an NI (Women with hypertensive disorders of pregnancy received prenatal care and NIs sessions until 7 days postpartum [NI cohort], n = 122), receiving structured education and behavioral sessions, or a routine prenatal care (PR cohort, n = 143). This investigation identifies a significant association between a protocolized NI and improved obstetric trajectories, particularly in younger women and those with a higher body mass index (BMI). While these associative findings are encouraging, the non-randomized, retrospective nature of the study necessitates caution, and the results should be viewed as hypothesis-generating rather than evidence of a definitive causal effect. The study population consisted of primigravida women with a median prepregnancy BMI of 23.8 kg/m2. The NI was independently associated with significantly higher odds of spontaneous vaginal delivery (adjusted odds ratios: 2.15; 95% confidence interval: 1.84-2.51; P < .001). The intervention was independently associated with a significant reduction in the risk of neonatal intensive care unit (NICU) admissions (adjusted odds ratios: 0.28; 95% confidence interval: 0.11-0.72; P = .008). Raw delivery outcomes also favored the NI cohort regarding normal delivery rates (45% vs 17%, P < .0001) and labor duration (82% vs 49%, P < .0001). Maternal complications were comparable, and nausea was significantly lower in the NI group (18% vs 29%, P = .032). Secondary neonatal outcomes demonstrated significant reductions in low birth weight (9% vs 15%, P = .048) and respiratory distress syndrome (3% vs 9%, P = .021). A NI was most effective for women aged ≤25 years and those with a BMI>24 kg/m2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.